Abstract session: HBV - Clinical

 Viral hepatitis

Channel 5
English
Abstract session
29 August 2020 11:00 - 12:30


Presentations

Title Time

Add to Calendar

AS091 A Phase 3 Study Comparing Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) with Continued TDF Treatment in Virologically-suppressed Patients with Chronic Hepatitis B (CHB): Final Week 96 Efficacy and Safety Results
29 August 2020 11:00 - 11:15
AS092 Immune checkpoint inhibitors and hepatitis B viral kinetics - a territory-wide cohort study
29 August 2020 11:15 - 11:30
AS093 Characterization of Serologic Responses Following ALT Flares in >3000 CHB patients Pooled from 5 Clinical Trials
29 August 2020 11:30 - 11:45
AS094 Tenofovir vs Entecavir on post-operative recurrence-free and overall survival of patients with hepatitis B virus-related hepatocellular carcinoma
29 August 2020 11:45 - 12:00
AS095 A prospective study of nucleot(s)ide analogue discontinuation in non-cirrhotic HBeAg-negative chronic hepatitis B patients: interim analysis at week 48 demonstrates profound reductions of HBsAg associated with ALT flare.
29 August 2020 12:00 - 12:15
AS169 High HBsAb titers consistent across 3 lots of the trivalent HepB vaccine, Sci-B-Vac: Results from the second pivotal phase 3 double-blind, randomized controlled trial designed to assess the lot-to-lot consistency of Sci-B-Vac in adults (CONSTANT)
29 August 2020 12:15 - 12:30